The science behind GLP-1: Why tirzepatide & semaglutide actually work
Inside the dual-hormone mechanism that's reshaping how clinicians approach sustainable weight loss — and what real members are seeing on the scale.
- GLP-1 medications work by mimicking a natural gut hormone that signals fullness.
- Tirzepatide targets both GLP-1 and GIP receptors — producing the largest weight loss of any FDA-approved drug to date.
- Most members see appetite changes in week 1 and visible weight loss by week 4–6.
- Slow titration is the single biggest factor in long-term tolerability.
For decades, sustainable weight loss felt out of reach for most people. Calorie restriction worked — until the body adapted. Exercise helped — until appetite caught up. The arrival of GLP-1 receptor agonists has fundamentally changed that equation, and the data behind them is now strong enough that the American Diabetes Association, the AHA, and major obesity-medicine societies have updated their treatment guidelines.
How GLP-1 rewires appetite
GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after eating. It signals fullness to the hypothalamus, slows gastric emptying so food stays in the stomach longer, and improves how your pancreas releases insulin in response to glucose. Semaglutide and tirzepatide are long-acting analogs — a single weekly injection keeps that 'I've eaten enough' signal active for seven days.
Why tirzepatide goes further
Tirzepatide adds a second target — the GIP receptor — which amplifies the effect on appetite, glucose handling, and how fat tissue stores energy. The SURMOUNT-1 trial showed up to 22.5% body weight loss over 72 weeks at the highest dose. For context, that's roughly double what bariatric medications could deliver a decade ago.
- GLP-1 alone (semaglutide): ~15% average weight loss
- GLP-1 + GIP (tirzepatide): up to 22.5% average weight loss
- Lifestyle alone (typical 12-month program): 3–5% average weight loss
What members typically see
Most Rejuviya members notice a quiet but unmistakable drop in food noise within the first week — the constant background chatter about snacks fades. Visible weight loss usually shows up between weeks 4 and 6, and the steady phase runs through months 3 to 6 as the dose is titrated up.
"The most striking thing isn't the number on the scale — it's that patients describe finally feeling at peace with food."
Ready to start your protocol?
A licensed physician reviews your profile and tailors treatment to you — typically within 24 hours.
Explore treatments
